Page last updated: 2024-09-05

esketamine and Affective Disorders

esketamine has been researched along with Affective Disorders in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's2 (100.00)2.80

Authors

AuthorsStudies
Cao, B; Cha, DS; Gill, H; Ho, R; Kratiuk, K; Lee, Y; Lipsitz, O; Lui, LMW; Mansur, RB; McIntyre, RS; Nasri, F; Ng, J; Rodrigues, NB; Rosenblat, JD; Subramaniapillai, M; Teopiz, KM; Xiong, J1
Cao, B; Ceban, F; Chau, EH; Gill, H; Ho, RC; Kratiuk, K; Kumar, A; Lee, JG; Lee, Y; Lin, K; Lipsitz, O; Lui, LMW; Mansur, RB; McIntyre, RS; Nasri, F; Rodrigues, NB; Rosenblat, JD; Subramaniapillai, M; Swainson, J1

Reviews

2 review(s) available for esketamine and Affective Disorders

ArticleYear
Ketamine-induced urological toxicity: potential mechanisms and translation for adults with mood disorders receiving ketamine treatment.
    Psychopharmacology, 2021, Volume: 238, Issue:4

    Topics: Adult; Antidepressive Agents; Depressive Disorder, Treatment-Resistant; Humans; Ketamine; Mood Disorders

2021
Prevention and Management of Common Adverse Effects of Ketamine and Esketamine in Patients with Mood Disorders.
    CNS drugs, 2021, Volume: 35, Issue:9

    Topics: Administration, Intranasal; Administration, Intravenous; Antidepressive Agents; Anxiety; Disease Management; Drug-Related Side Effects and Adverse Reactions; Gastrointestinal Diseases; Humans; Ketamine; Mood Disorders; Nausea

2021